Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI coach vs. weight-loss shot: which helps keep pounds off longer in diabetes?

NCT ID NCT07555730

First seen May 01, 2026 · Last updated May 24, 2026 · Updated 4 times

Summary

This study tests whether an AI-guided lifestyle program or continuing the drug tirzepatide is better at helping adults with type 2 diabetes and overweight maintain weight loss. All 400 participants first take tirzepatide for 20 weeks, then those who lose enough weight are randomly assigned to either the AI program or a lower dose of tirzepatide for another 52 weeks. The goal is to see which approach works best for long-term weight control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WEIGHT LOSS MAINTENANCE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.